I am Dr. Jong-Won Kim, Ph.D., currently serving as an Assistant Professor in the Department of Pharmacology at the College of Medicine, Gyeongsang National University in South Korea. I received my combined Master’s and Ph.D. degrees in Veterinary Pathology from Jeonbuk National University and completed my postdoctoral fellowship at the University of Pittsburgh. My research focuses on the cell-type-specific molecular mechanisms that underlie the pathogenesis and progression of acute and chronic liver diseases. I strive to understand how various cell types—such as hepatocytes, Kupffer cells, and hepatic stellate cells—contribute differently to disease states. Using integrative approaches that involve metabolomics, post-translational modifications, and animal disease models, I aim to uncover therapeutic targets with translational potential. What distinguishes my work is its emphasis on cellular specificity and the integration of systems biology to address liver pathology. To date, I have authored or co-authored over 30 first or corresponding-author publications in internationally recognized journals, including Hepatology, Science Translational Medicine, Pharmacological Reviews, and American Journal of Pathology. I have given multiple presentations at international conferences, and my work has been cited more than 1,400 times, with a Google Scholar H-index of 20. I have received awards such as the Outstanding Paper Award from the Asian Society of Toxicology and the Excellent Paper Award from the Korean Society of Toxicology. I am also an active member of several professional societies in the fields of toxicology, pharmacology, and hepatology. In addition to publishing, I have contributed to academic journals by peer-reviewing over 70 manuscripts and writing several invited editorials. These experiences have deepened my engagement with the global scientific community and sharpened my ability to critically evaluate emerging science. My long-term research goal is to define the molecular signatures and regulatory networks involved in metabolic liver diseases and fibrosis, with a focus on redox biology and immune-metabolic interactions. I aim to develop new strategies for liver disease prevention and treatment through a mechanistic and cell-specific approach. I bring to my work strong communication and leadership skills, along with mentoring, project management, and interdisciplinary problem-solving abilities. These professional qualities help me build collaborative research environments and support the development of junior scientists. Outside of academia, I enjoy hiking, exploring new cuisines, and reading nonfiction books, all of which keep me grounded and intellectually inspired.